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ORIGINAL ARTICLE
Urothelial carcinoma (UC) of the renal pelvis and
ureter is relatively rare in the West, with an esti-
mated incidence of only 1–5% of all urinary tract
UC.1,2 In areas of Taiwan endemic for blackfoot
disease, however, the reported incidence ranges
from 20% to 31%.3,4 The reported ratio of renal
pelvis UC to ureter UC to bladder UC in the West
is approximately 3:1:51, which is considerably
different from that in Taiwan.5
Patients with end-stage renal disease (ESRD)
who undergo hemodialysis or renal transplanta-
tion are considered to be at high risk for UC.6–8
Maisonneuve et al reported that the incidence of
cancer, especially in the kidney and urinary tract,
was higher in patients on maintenance dialysis
compared to the general population.9 Ou et al
also reported that the incidence of UC in dialysis
patients was 0.89%, which is higher than in the
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retrospectively analyzed to determine the clinical profile, overall survival and correlation with CKD.
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stage UUT-UC had significantly worse prognosis than those with low grade (p = 0.0047) and low stage
(p = 0.0021). Of the 110 patients, 64 (58%) had impaired renal function (glomerular filtration rate < 60 mL/
min/1.73 m2; defined as CKD), including 14 (13%) with end-stage renal disease (ESRD) before diagnosis.
Patients with CKD or ESRD had significantly worse prognosis than those with normal renal function
(p=0.0399). High grade UC was found in 35 of 58 patients with CKD or ESRD (60%), which was significantly
higher than in patients with normal renal function (12/26, 26%; p = 0.019).
Conclusion: A high proportion of UUT-UC was observed among all UCs and a significantly higher per-
centage of high grade UUT-UC (60%) were found in patients with CKD or ESRD in eastern Taiwan. These
findings suggest that CKD and ESRD might play a role in the development of UC especially in the upper
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general population in Taiwan.10 Their study of
dialysis patients suggested that immunosuppres-
sive stage, dialysis procedure, and chronic bladder
irritation (decreased urinary wash effect) might be
risk factors for the development of UC.10 It is pos-
sible that chronic kidney disease (CKD) may also
play a role in the development of UC, especially
in the upper urinary tract (UUT). However, pre-
viously reported data did not demonstrate a link
between CKD and UUT-UC. In this single-center
study, we retrospectively analyzed data from 110
patients with histologically proven UUT-UC over
a 20-year period to determine the ratio of UC at
different locations, the differences in clinical pro-
file and differences in overall survival. We also ana-
lyzed the association between CKD and UUT-UC.
Methods
The medical records of 470 consecutive patients
with histologically proven UC and 160 patients
with a diagnosis of renal cancer at Hualien Tzu
Chi General Hospital from January 1990 through
April 2006 were reviewed. Patients with primary
UC of the renal pelvis and/or ureter were included
in the analysis. Data collected for each patient
included gender, age, tumor location, presence
of synchronous multiple UC at diagnosis, tumor
grade according to the World Health Organization
system, tumor stage according to the TNM classi-
fication, creatinine levels at diagnosis, and clini-
cal signs and symptoms. Cancer-specific survival
was estimated based on data from the time of
pathologic diagnosis until the end of the study
period on April 30, 2006.
Estimated glomerular filtration rate (GFR)
was calculated with the Modification of Diet 
in Renal Disease (MDRD) study equation.11 The
MDRD-GFR was calculated as 186 × (serum crea-
tinine)−1.154 × (age)−0.203 × (0.742 if female). Ac-
cording to the recommendation of the Kidney
Disease Outcomes Quality Initiative (K/DOQI) of
the National Kidney Foundation,12 CKD was rec-
ognized to have five stages: stage 1—normal GFR
(>90mL/min/1.73m2); stage 2—mild reduction in
GFR (60–89 mL/min/1.73 m2); stage 3—moderate
reduction in GFR (30–59 mL/min/1.73 m2); stage
4—severe reduction in GFR (15–29 mL/min/
1.73 m2); stage 5—kidney failure (GFR < 15 mL/
min/1.73 m2 or on dialysis). In this study, an es-
timated preoperative GFR < 60 mL/min/1.73 m2
was considered to indicate CKD.
Patients were classified as having ESRD if they
had received regular dialysis before surgical treat-
ment for UUT-UC or they had received renal trans-
plantation before the diagnosis of UC arising from
native kidneys.
Pearson’s χ2 test was used for analysis of the
association between tumor grade and differences
in renal function. Survival estimates were obtained
using the Kaplan–Meier method with log rank test.
A p value of less than 0.05 was considered to be
statistically significant.
Results
A total of 110 patients with a pathologic diagno-
sis of UC of the renal pelvis and/or ureter were
included in the analysis. The mean age at the
time of diagnosis was 68.69 ± 9.8 years (range,
43–93 years), and the male to female ratio was 
1 to 1.16 (51:59). At diagnosis, 67 UC were located
in the renal pelvis, 54 were located in the ureter
and 21 (19%) patients had synchronous involve-
ment (Table 1). The overall ratio of UC of the renal
pelvis to UC of the ureter to UC of the bladder
was approximately 1.2:1:6.7. UC of the renal pelvis
accounted for 10.8% of all urinary tract UC, and
for approximately 41% of all renal cancer detected
during the study period in our hospital. Among
the 110 patients, 83 received nephroureterectomy
with bladder cuff resection, seven received nephrec-
tomy, 16 received cystoureteroscopic or sono-
guided percutaneous renal biopsies and four
were treated by segmental resection of the ureter.
Kaplan–Meier survival analysis estimated the
2-, 5- and 10-year cancer-specific cumulative sur-
vival rates to be 75%, 53% and 29%, respectively.
Univariate analysis using the log-rank test found
no significant difference in cancer-specific survival
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between patients with renal pelvis UC and pa-
tients with ureter UC (Figure 1). Of the 99 pa-
tients with available data on histologically proven
tumor grading, 52 patients (53%) were low grade
and 47 (47%) were high grade. Patients with high
grade and high stage (T ≥3) had significantly worse
prognosis than those with low grade and low stage
(p = 0.0047 and p = 0.0021, respectively; Figures 2
and 3). Of the 104 patients with available data,
64 (61%) had CKD (50, 48%) or ESRD (14, 13%)
before the diagnosis of UC. Patients with CKD or
ESRD had significantly worse prognosis than those
with normal renal function (p = 0.0399; Figure 4).
High grade UC was found in 35 of 58 patients
with CKD or ESRD (60%), which was significantly
higher than in patients with normal renal function
(12/26, 26%; p = 0.019).
Discussion
UUT-UC involving the renal pelvis and ureter is
relatively uncommon compared with bladder UC
in Western countries; the ratio of UC involving the
renal pelvis to ureter UC to bladder UC was ap-
proximately 3:1:51.5 In this study, however, the
ratio of UC involving the renal pelvis to ureter UC
to bladder UC was 1.2:1:6.7, which is similar to the
ratio of 1.1:0.9:8 reported by Chou and Huang
from Taiwan.3 UUT-UC accounted for 23.4% of
Table 1. Characteristics of 110 patients with 121 upper urinary tract urothelial carcinomas (UC)
All patients Patients with renal Patients with ureter UC 
(N = 110) pelvis UC (n = 67) (n = 54)
Age (yr)
Range 43–93 43–93 44–81
Mean ± SD 68.69 ± 9.76 68.60 ± 10.63 68.46 ± 8.35
Sex, n
Male 51 32 23
Female 59 35 32
Synchronous multiple tumors at diagnosis, n
Yes 21 14 17
No 89 53 31
Tumor grade
Low 52 29 30
High 47 29 20
Undetermined 11
T stage
T1 56 27 31
T2 16 12 6
≥ T3 24 17 9
Undetermined 14
Presence of lymph node or distal metastasis 10
GFR (mL/min/1.73 m2) 104 63 50
≥ 60 40 25 20
< 60 50 31 23
ESRD 14 7 7
Duration of follow-up (mo), mean ± SD 36.3 ± 43.12
SD = standard deviation; GFR = glomerular filtration rate; ESRD = end-stage renal disease.
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Figure 1. Kaplan–Meier estimated
cancer-specific survival curves for
patients with upper urinary tract
urothelial carcinoma (UC), renal 
UC and ureter UC.
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Figure 2. Kaplan–Meier estimated
cancer-specific survival curves 
for patients with upper urinary
tract urothelial carcinoma of 
different grades.
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Figure 3. Kaplan–Meier estimated
cancer-specific survival curves 
for patients with upper urinary
tract urothelial carcinoma of 
different T stages.
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all urinary tract UC in the present study, which is
much higher than the incidence of 1–5% reported
in previous studies.2,5,6 Among all tumors of the
kidney, the percentage of UC of the renal pelvis was
also unusually high (41%) in this study. Regarding
the relationship between sex and incidence of
UUT-UC, this study found that men and women
had almost the same incidence of UUT-UC, al-
though there was a slight female predominance
(M:F = 1:1.16). This study’s findings on the sex
ratio of UC, the ratio of UC of the renal pelvis to
ureter to bladder, and the ratio of UC of the renal
pelvis to all renal carcinomas were different from
those of most previous studies from the West but
similar to data reported by Chou and Huang from
Taiwan (Table 2).3 The proportion of UUT-UC
among all UC in Taiwan appears to be higher than
that in Western countries.
The incidence of urinary tract UC in the area
endemic for blackfoot disease in Southern Taiwan
is significantly higher than anywhere else in the
world except Balkan endemic area.7,8 About one
third of patients in Chou and Huang’s study lived
in the area of Taiwan where blackfoot disease is
endemic. Although none of the patients in this
study were residents in the area endemic for black-
foot disease, the proportion of UUT-UC was nearly
the same as in Chou and Huang’s study, which
suggests that a high ratio of UUT-UC also occurs
in areas other than areas endemic for blackfoot
disease in Taiwan. Thus, it may be that in addition
to high-arsenic artesian well water, other yet to be
identified exposure origins or risk factors might
have a contributing role in the development of
UUT-UC in Taiwan.
High grade UC has a higher metastatic poten-
tial, lethality, recurrence rate, and invasiveness than
low grade UC.13 A review of 164 patients with
UUT-UC and 2197 with bladder UC by Stewart 
et al found that UUT-UC is a higher grade disease
than bladder UC, with 44% and 35% of grade III
tumors, respectively (p = 0.003).14 In this study,
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Figure 4. Kaplan–Meier esti-
mated cancer-specific survival
curves for patients with upper
urinary tract urothelial carci-
noma and different renal 
function. GFR = glomerular 
filtration rate; HD =
hemodialysis.
Table 2. Comparison of gender predominance and incidence of upper urinary tract urothelial carcinoma in
the present study and previous studies from Taiwan and Western countries
Western countries
Taiwan
Chou & Huang (1999)3 Yang et al (2002)4 This study
M:F ratio 3:1 1:1.3 1:1.16
Renal/ureter/bladder 3:1:51 1.1:0.9:8 1:2.08:6.72 1.2:1:6.7
Renal pelvis/all renal tumors 5–10% 40% 41%
Upper/all urothelial tumors 4% 20% 31% 10.8%
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47.5% (47/99) of UUT-UC were high grade, in-
dicating that UUT-UC should be regarded as a
more aggressive and invasive cancer than bladder
UC. We also found that patients with high grade
and high stage UC had worse prognosis than those
with low grade and low stage UC (p = 0.001 and
p = 0.002, respectively). These findings illustrate
the importance of early diagnosis and accurate
grading and staging of UUT-UC.
The correlation between UUT-UC and CKD is
of great concern. More than half of the patients
in this study (58%) with UUT-UC had CKD or
ESRD. Renal transplant recipients or patients with
CKD have been shown to have a high risk of
UC.15 The majority of recent reports on the rela-
tionship between UC and ESRD come from Eastern
countries such as Taiwan and Japan. According
to the cancer registry annual report for 2002 in
Taiwan, the annual incidence of bladder and renal
pelvic cancer was 7.13 and 3.73 per 100,000 per-
sons.16 Chen et al reported that the standardized
incidence of kidney cancer including UC and other
types was 24.1 times higher in dialysis patients
than in the general population of Taiwan.17 An-
other study from Taiwan reported an incidence
of UC of 0.9% (15/1910) in dialysis patients over
10 years of follow-up.10 Yang et al’s study from
Taiwan also found a higher proportion of UUT-
UC among all urinary tract UC (47%) in patients
with renal failure.4 In the present study, we not
only found that a higher proportion (61%) of
UUT-UC patients had CKD or ESRD but also that
patients with CKD or ESRD (35/58, 60%) had 
a higher ratio of high grade cancer than patients
with normal renal function. Therefore, in addition
to ESRD, we suggested that CKD might also be
contributory to the development of UUT-UC.
Kazutaka et al’s review of data from 47 patients
who were on maintenance hemodialysis and who
had primary bladder UC showed that grade III
tumors accounted for 63% of all patients irrespec-
tive of the duration of hemodialysis.18 They also
suggested that the duration of CKD played a more
important role than the duration of hemodialy-
sis in the occurrence of high grade UC. Wu et al 
reviewed data from 73 patients on hemodialysis
with UUT-UC and found that most patients had
superficial stage and low grade (67.1%) tumors
and only 18 (24.6%) patients had high grade tu-
mors, suggesting the possibility of early diagnosis
of UC in hemodialysis patients.19 This diagnostic
pattern, however, differs from our results and those
of other reports, indicating the need for further
investigation of the role of CKD in the develop-
ment of high grade UC and UUT-UC.
The reasons for the high risk of UC in pa-
tients with uremia are not clear. Cosyns et al20
and Nortier et al21 reported a high prevalence of
UUT-UC in patients with Chinese herb nephropa-
thy, which was associated with the use of car-
cinogenic remedies containing aristolochic acid.
Aristolochic acid or other unknown substances in
herbal medicines might be responsible for both
toxic uremia and development of UC. Immuno-
suppressive stage, dialysis procedure and chronic
irritation have also been suggested as etiologies
of UC. Further investigation of the carcinogens
that may contribute to UC in patients with CKD
are mandatory.
In summary, a high proportion of UUT-UC was
noted among all UC and a significantly higher
percentage of high grade UUT-UC (60%) was
found in patients with CKD or ESRD in eastern
Taiwan. These results suggest that CKD might play
a role in the development of UC, especially in
the upper urinary tract.
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